MARKET

ADPT

ADPT

Adaptive Biotechnologies
NASDAQ
10.53
-0.31
-2.82%
Opening 14:13 07/17 EDT
OPEN
10.84
PREV CLOSE
10.83
HIGH
10.85
LOW
10.51
VOLUME
740.27K
TURNOVER
--
52 WEEK HIGH
12.43
52 WEEK LOW
3.845
MARKET CAP
1.60B
P/E (TTM)
-10.9727
1D
5D
1M
3M
1Y
5Y
1D
Adaptive Biotechnologies Corporation to Report Second Quarter 2025 Financial Results
Reuters · 1d ago
Weekly Report: what happened at ADPT last week (0707-0711)?
Weekly Report · 3d ago
Northern Technologies: Fiscal Q3 Earnings Snapshot
Barchart · 07/10 07:08
Weekly Report: what happened at ADPT last week (0630-0704)?
Weekly Report · 07/07 09:23
Adaptive, Flatiron Health integrates clonoSEQ MRD testing into OncoEMR
TipRanks · 07/01 11:41
Adaptive Biotechnologies Integrates Adaptive's clonosSEQ Test For MRD Assessment In Lymphoid Malignancies Into OncoEMR, Flatiron's Cloud-Based EMR Platform
Benzinga · 07/01 11:31
Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
Barchart · 07/01 06:30
Weekly Report: what happened at ADPT last week (0623-0627)?
Weekly Report · 06/30 09:24
More
About ADPT
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company. The Company is focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. It applies its platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across its two business segments: Minimal Residual Disease (MRD) and Immune Medicine. The MRD business focuses on the use of its sensitive, next-generation sequencing (NGS) assay to measure MRD in patients with hematologic malignancies. Its MRD business is comprised of its clonoSEQ clinical diagnostic test, offered to clinicians. The IM business focuses on the discovery and development of transformative immune-based therapies in the treatment of patients with cancer and autoimmune diseases.

Webull offers Adaptive Biotechnologies Corp stock information, including NASDAQ: ADPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADPT stock methods without spending real money on the virtual paper trading platform.